MRS-1706

CAS: 264622-53-9

Ref. 3D-PKA62253

Informação sobre produto

• Nome: MRS-1706
• Sinónimos: Acetamide, N-(4-acetylphenyl)-2-[4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-, MRS 1706, Acetamide, N-(4-acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]-, N-(4-Acetylphenyl)-2-[4-(2,3,6,9-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenoxy]acetamide

Descrição

MRS-1706 is a compound that inhibits the effect of ATP on P2Y receptors. MRS-1706 has been shown to be effective in reducing inflammation and suppressing the proliferation of cells, which are associated with primary sclerosing cholangitis (PSC). The drug also has an inhibitory effect on adenosine production by affecting the mitochondrial membrane potential and Ca2+ overload. MRS-1706 can reduce camp levels, inhibit receptor activity and increase gamma-aminobutyric acid levels, leading to decreased cellular proliferation. MRS-1706 also binds to A3 adenosine receptors, which leads to a reduction in cell proliferation.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 503.55 g/mol
• Fórmula: C₂₇H₂₉N₅O₅
• Pureza: Min. 95%